Sagimet Biosciences Inc. Series A Common Stock (SGMT) Stock Analysis

Sagimet Biosciences Inc. Series A Common Stock (SGMT) is a publicly traded company in the HEALTHCARE sector. It trades at $6.79, carries a market capitalization of $444.00M. This page summarizes the public market data, fundamentals, and frequently asked questions for SGMT, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $6.79
• Market Cap: $444.00M
• EPS: $-1.35
• 52-Week High: $11.41
• 52-Week Low: $3.83

Market Sentiment

Sagimet Biosciences Inc. Series A Common Stock currently has a Neutral sentiment score of 0.08.

About Sagimet Biosciences Inc. Series A Common Stock

None

GNG Research Analysis

GNG Research scores Sagimet Biosciences Inc. Series A Common Stock (SGMT) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for SGMT.

Frequently Asked Questions

Does SGMT pay dividends?

Sagimet Biosciences Inc. Series A Common Stock (SGMT) does not currently pay a regular dividend.

What is SGMT's market cap?

Sagimet Biosciences Inc. Series A Common Stock (SGMT) has a market capitalization of $444.00M with a current stock price of $6.79.